Opendata, web and dolomites

GDA in staphylococci

Gen Duplication and Amplification in Staphylococcal populations

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GDA in staphylococci project word cloud

Explore the words cloud of the GDA in staphylococci project. It provides you a very rough idea of what is the project "GDA in staphylococci" about.

pathogens    comprising    environmental    natural    rapid    scaffold    apparent    infections    biological    gene    cf    gdas    material    staphylococcus    antibiotics    showed    bacterial    387    regarding    changing    almost    unanswered    difficulties    mechanisms    resistances    detection    model    determinant    genetic    acquiring    optimize    technologies    extend    clinically    data    suffering    identification    sequences    qpcr    sequencing    causing    ngs    techniques    evolutionary    regions    ca    environment    species    clinical    copy    accordingly    valuable    hospital    readily    exclusively    alter    validation    additional    infection    exemplarily    aureus    transfer    questions    gen    chronic    horizontal    gda    isolates    amplifications    dosage    antibiotic    virulence    experimental    possess    putative    1200    patients    variation    acquire    sequence    minor    avenues    fibrosis    experiments    adaption    extract    adapt    setting    organisms    coverage    duplications    resistance    setups    usa300    groundbreaking    besides    emrsa15    frequency    pressure    bacteria    genome    cystic    lung    populations    genomic   

Project "GDA in staphylococci" data sheet

The following table provides information about the project.

Coordinator
EBERHARD KARLS UNIVERSITAET TUEBINGEN 

Organization address
address: GESCHWISTER-SCHOLL-PLATZ
city: TUEBINGEN
postcode: 72074
website: www.uni-tuebingen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website http://www.imit.uni-tuebingen.de/arbeitsgruppen/infektionsbiologie/ag-heilbronner.html
 Total cost 171˙460 €
 EC max contribution 171˙460 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2014
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2016
 Duration (year-month-day) from 2016-01-01   to  2018-03-02

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    EBERHARD KARLS UNIVERSITAET TUEBINGEN DE (TUEBINGEN) coordinator 171˙460.00

Map

 Project objective

Bacterial pathogens possess the ability to adapt rapidly to changing environmental conditions which is especially apparent in the hospital setting where bacteria acquire antibiotic resistances readily. Besides well studied mechanisms such as horizontal gene transfer bacteria can alter the genetic material by acquiring gen duplications and amplifications (GDA). Exemplarily an improved gene dosage of a minor resistance determinant can lead to increased resistance to antibiotics. Due to the difficulties in their detection GDAs are almost exclusively studied in model organisms and neglected in natural populations of clinically relevant species such as Staphylococcus aureus. Accordingly many important questions about the frequency and clinical importance of GDAs remain unanswered. State of the art sequencing technologies enable the identification of GDAs by analysis of the coverage scaffold and groundbreaking experiments using 387 USA300 genome sequences showed promising results regarding putative copy number variation of virulence factors. We will extend the GDA analysis to ca. 1200 already available EMRSA15 sequences. This will enable a comprising analysis of gen copy number variation in clinical isolates and might allow identifying genomic regions under strong evolutionary pressure during infection. We will optimize experimental setups for the rapid validation of GDAs by qPCR and develop techniques to study the effects of GDAs in S. aureus. Furthermore we will sequence a selection ca. 70 S. aureus isolates causing chronic infections in patients suffering from cystic fibrosis (CF). This will enable us to optimize the detection of GDAs by NGS and will allow investigating the role of GDAs during adaption to the complex environment within the CF-lung. This project will show new avenues to extract additional valuable biological information from NGS data and will investigate the importance of GDAs during the adaption of S. aureus to the hospital setting and to the CF-lung.

 Publications

year authors and title journal last update
List of publications.
2016 Simon Heilbronner, Ian R. Monk, Jeremy R. Brozyna, David E. Heinrichs, Eric P. Skaar, Andreas Peschel, Timothy J. Foster
Competing for Iron: Duplication and Amplification of the isd Locus in Staphylococcus lugdunensis HKU09-01 Provides a Competitive Advantage to Overcome Nutritional Limitation
published pages: e1006246, ISSN: 1553-7404, DOI: 10.1371/journal.pgen.1006246
PLOS Genetics 12/8 2019-06-13

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GDA IN STAPHYLOCOCCI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GDA IN STAPHYLOCOCCI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

STIMOS (2019)

Stimulation of Multiple Organoids Simultaneously

Read More  

MarshFlux (2020)

The effect of future global climate and land-use change on greenhouse gas fluxes and microbial processes in salt marshes

Read More  

BIOplasma (2019)

Use flexible Tube Micro Plasma (FµTP) for Lipidomics

Read More